HRT FINANCIAL LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,637
-99.9%
267,997
+92.2%
0.02%
+42.9%
Q3 2022$1,336,000
-62.3%
139,467
-34.5%
0.01%
-44.0%
Q1 2022$3,546,000
+183.7%
212,974
+225.1%
0.02%
+257.1%
Q4 2021$1,250,000
-29.3%
65,514
-8.6%
0.01%
-36.4%
Q3 2021$1,768,000
-52.9%
71,704
-11.4%
0.01%
-85.5%
Q4 2020$3,756,000
+22.1%
80,965
-27.8%
0.08%
-17.4%
Q2 2020$3,077,000112,0980.09%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders